GfK SE:企業の戦略・SWOT・財務情報

◆英語タイトル:GfK SE - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3701
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

GfK SE – Strategy, SWOT and Corporate Finance Report
Summary

GfK SE – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

GfK SE (GfK or “the company”) is a provider of market and consumer information designed for consumers to make informed decisions. Gfk provides services such as brand and customer experience, digital market intelligence, distribution and supply chain management, geomarketing, market opportunities and innovation, media measurement, mystery shopping among others. The company has its presence in Europe, the Americas, the Middle East, Africa and Asia Pacific. GfK is headquartered in Nuremberg, Germany.

Scope

- Detailed information on GfK SE required for business and competitor intelligence needs
- A study of the major internal and external factors affecting GfK SE in the form of a SWOT analysis
- An in-depth view of the business model of GfK SE including a breakdown and examination of key business segments
- Intelligence on GfK SE’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about GfK SE, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of GfK SE and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess GfK SE as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on GfK SE’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
GfK SE: Company Overview 8
GfK SE: Overview and Key Facts 8
GfK SE: Overview 8
GfK SE: Key Facts 8
GfK SE: Key Employees 9
GfK SE: Key Employee Biographies 11
GfK SE: Major Products and Services 15
GfK SE: Company History 16
GfK SE: Management Statement 20
GfK SE: Locations and Subsidiaries 22
GfK SE: Key Competitors 25
GfK SE: Company Analysis 26
GfK SE: Business Description 26
GfK SE: SWOT Analysis 27
GfK SE: SWOT Overview 27
GfK SE: Strengths 27
GfK SE: Weaknesses 28
GfK SE: Opportunities 28
GfK SE: Threats 29
GfK SE: Corporate Financial Deals Activity 30
GfK SE: Financial Deals Overview 30
GfK SE: Targets and Partners 32
GfK SE: Top Deals 2014 – 2018YTD* 33
GfK SE: Advisors 34
GfK SE: Top Legal Advisors 34
GfK SE: Mergers and Acquisitions 35
GfK SE: Divestments 36
GfK SE: Private Equity and Ownership 37
GfK SE: Recent Developments 38
GfK SE: News and Events Summary 38
GfK SE: Business Expansion 39
GfK SE: Corporate Governance 39
Appendix 41
Contact Us 41
Methodology 41
About MarketLine 42

List of Tables
Table 1: GfK SE: Key Facts
Table 2: GfK SE: Key Employees
Table 3: GfK SE: Locations and Subsidiaries
Table 4: GfK SE: Key Competitors
Table 5: GfK SE: Deal Activity by Deal Type - Volume (TTM*)
Table 6: GfK SE: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: GfK SE: Targets and Partners
Table 8: GfK SE: Top Deals 2014 - 2018YTD*
Table 9: GfK SE: Legal Advisor Ranking by Value (US$m)
Table 10: GfK SE: M&A Volume and Value Trend (2014 - YTD*2018)
Table 11: GfK SE: M&A Activity by Geography (2014 - YTD*2018)
Table 12: GfK SE: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 13: GfK SE: Divestments by Geography (2014 - YTD*2018)
Table 14: GfK SE: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 15: GfK SE: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 16: GfK SE: News and Events Summary
Table 17: GfK SE: Business Expansion
Table 18: GfK SE: Corporate Governance

List of Figures
Figure 1: GfK SE: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: GfK SE: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: GfK SE: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: GfK SE: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: GfK SE: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 6: GfK SE: Divestments by Geography (2014 - YTD*2018)
Figure 7: GfK SE: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 8: GfK SE: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[GfK SE:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Teck Resources Ltd:戦略・SWOT・企業財務分析
    Teck Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Teck Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Baker & McKenzie LLP:企業の戦略的SWOT分析
    Baker & McKenzie LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Edison International:企業の戦略・SWOT・財務分析
    Edison International - Strategy, SWOT and Corporate Finance Report Summary Edison International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • SurModics Inc (SRDX):企業の財務・戦略的SWOT分析
    SurModics Inc (SRDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mitsui & Co., Ltd.:企業の戦略・SWOT・財務情報
    Mitsui & Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsui & Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • FuelCell Energy Inc (FCEL):電力:M&Aディール及び事業提携情報
    Summary FuelCell Energy Inc (FuelCell Energy) is an integrated fuel cell company that designs, manufactures, installs, operates, and services stationary fuel cell power plants for distributed power generation. The company offers proprietary fuel cell products based on carbonate fuel cell technology. …
  • The New York Times Company (NYT):企業の財務・戦略的SWOT分析
    The New York Times Company (NYT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Clalit Health Services:企業の戦略的SWOT分析
    Clalit Health Services - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Novita Healthcare Ltd (NHL):製薬・医療:M&Aディール及び事業提携情報
    Summary Novita Healthcare Ltd (Novita Healthcare), formerly Avexa Ltd is a medical technology company that focuses on the measurement and treatment of attention difficulties in early childhood. The company operates through its subsidiary The Tali technology, which is developing a tablet based softwa …
  • Revalesio Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Revalesio Corp (Revalesio) is a developer of novel therapeutics for the treatment of inflammatory diseases. The company conducts research and development activities to develop therapeutics in the areas of respiratory, neuroscience and cardiovascular. Its product pipeline includes drugs targe …
  • Bord na Mona Plc:企業の戦略的SWOT分析
    Bord na Mona Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • China Resources Pharmaceutical Group Ltd (3320)-製薬・医療分野:企業M&A・提携分析
    Summary China Resources Pharmaceutical Group Ltd (CR Pharma), a subsidiary of China Resources (Holdings) Co Ltd is a pharmaceutical company that offers nutritional supplements. The company offers research and development, manufacture, and distribution of whole drug products. Its products comprise ch …
  • Turbo Power Systems Ltd:企業の戦略的SWOT分析
    Turbo Power Systems Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Sensimed AG-医療機器分野:企業M&A・提携分析
    Summary Sensimed AG (Sensimed) is a medical device company that offers soft contact lens-based solutions. The company’s products comprise Sensimed Triggerfish, a non-invasive soft contact lens-based solution designed for the overall management of glaucoma. It offers automated recording of continuous …
  • Re-Vana Therapeutics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Re-Vana Therapeutics Ltd (Re-Vana) is an ocular pharmaceutical and drug delivery company that develops and commercialization of biodegradable long- acting drug delivery platforms to treat ophthalmic conditions. The company provides drug delivery products such as OcuLief, an injectable platfo …
  • Five Prime Therapeutics Inc (FPRX):企業の財務・戦略的SWOT分析
    Five Prime Therapeutics Inc (FPRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Accrol Group Holdings PLC (ACRL):企業の財務・戦略的SWOT分析
    Accrol Group Holdings PLC (ACRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • HD Supply Holdings, Inc.:企業の戦略・SWOT・財務情報
    HD Supply Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary HD Supply Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • ICON Health & Fitness, Inc.:企業の戦略・SWOT・財務情報
    ICON Health & Fitness, Inc. - Strategy, SWOT and Corporate Finance Report Summary ICON Health & Fitness, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Syros Pharmaceuticals Inc (SYRS):企業の財務・戦略的SWOT分析
    Summary Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The company’s pipeline products under clinical trials include SY-1425, an oral, potent and selective RARa agonist that is used t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆